Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341363 · ClinicalTrials.gov registry record · NA
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
A NA study of Androgenic Alopecia, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04341363: Completed NA study of Androgenic Alopecia, sponsored by Yale University.
NCT04341363 is a NA study of Androgenic Alopecia that has completed, run by Yale University. The registered enrollment target is 8 participants, below the 75-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04341363, a NA study of Androgenic Alopecia, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
Primary Outcome
Total number of hairs in an area of 1 cm\^2
Conditions Studied
Interventions
- DEVICE Tattoo machine
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-05-02 |
| Phase | NA |
What the finished NCT04341363 record still lists
NCT04341363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 75-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Tattoo machine is the first listed.
NCT04341363 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04341363 about?
NCT04341363 is a clinical study titled "Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling". The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
What is the current status of trial NCT04341363?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-04-09. Estimated completion is 2022-05-02.
What conditions does trial NCT04341363 study?
This clinical trial studies the following conditions: Androgenic Alopecia.
What interventions are being tested in trial NCT04341363?
The interventions under investigation include: Tattoo machine (DEVICE).
Who is sponsoring clinical trial NCT04341363?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04341363 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Computer-Assisted Hair Restoration Study Using ARTAS System
RECRUITING · NA
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
RECRUITING · NA
-
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI